Cosmo and Glenmark receives market authorization for Winlevi in Europe
Cosmo Pharmaceuticals and Glenmark Pharmaceuticals, announced that the European Commission (EC) has granted Marketing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenmark
IPA announces leadership transition
Sharvil Patel, MD, Zydus Lifesciences and former VP, IPA, assumes the role of President,; Glenn Saldanha, Chairman and MD,…
Indian pharma companies focus on innovative research in foreign countries through dedicated entities
According to GlobalData’s Pharmaceutical Intelligence Center, as of 20 December 2024, there are a total of 16 drugs in the…
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg
The drug as been determined by the FDA to be bioequivalent and therapeutically equivalent to Topamax Capsules
Glenmark and IADVL undertake awareness campaign supporting vitiligo patients in India
Glenmark released Picture Post Cards in collaboration with the Indian Association of Dermatologists, Venereologists, and…
Glenmark gets USFDA nod for Esomeprazole Magnesium DR Capsules USP, 20 mg
Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC) is a medication for GERD
Glenmark creates mass awareness around Hypertension
To mark ‘Hypertension Awareness Month’, Glenmark organises public awareness rallies and screening camps to create awareness around…
Glenmark and BeiGene partner to market cancer drugs in India
Both the companies enter into an agreement for marketing and distribution of Tislelizumab and Zanubrutinib in India
Glenmark launches the next phase of ‘India First Heart First’ Campaign
The initial phase of the campaign kicked off with an event on World Heart Day on September 29, 2023. The initiative seeks to…
Glenmark receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution,…
Glenmark’s Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% has been determined by the FDA to be…